Parvovirus B19 infection after renal transplantation;Infection à parvovirus B19 et transplantation rénale

Nephrologie

Volumn 24, Issue 6, 2003, Pages 309-315

  Rerolle, Jean Philippe ^a   Helal, I ^a   Morelon, E ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Complication; Diagnosis; Parvovirus B19; Renal transplantation; Treatment

Indexed keywords

ANTIVIRUS AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADOLESCENT; ADULT; ANEMIA; ARTHRITIS; ARTICLE; CLINICAL FEATURE; CONVALESCENCE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; GLOMERULONEPHRITIS; HEPATITIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MYOCARDITIS; NONHUMAN; PARVOVIRUS; PATHOGENESIS; POLYMERASE CHAIN REACTION; SCHOOL CHILD; SERODIAGNOSIS; SEROLOGY; SEROPREVALENCE; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS TRANSMISSION;

HUMANS; KIDNEY TRANSPLANTATION; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 0141533022     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Yoshikawa T, Suga S, Asano Y. Human herpesvirus-6 infection in bone marrow transplantation. Blood. 1991; 78: 1381-4.
2. Neild G, Anderson M, Hawes S, Colvin B. Parvovirus infection after renal transplant. Lancet 1986; 2: 1226-7.
3. Cossart Y, Field A, Cant B, DW. Parvovirus-like particles in human sera. Lancet 1975; 1: 72-3.
4. Reid D, Reid T, Brown T, Rennie J, Eastmond C. Human parvovirus-associated arthitis: A clinical and laboratory description. Lancet 1985; 1: 422-5.
5. Anand A, Gray E, Brown T, Clewley J, Cohen B. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987; 316: 183-6.
6. Mougdil A, Nast C, Bagga A, Wei L, Nurmamet A, Cohen A, Jordan S, Toyoda M. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 2001; 59: 2126-33.
7. Berns KWWH. Adeno-associated virus DNA structure and replication. Berns KI, ed. The parvoviruss. New York-London: Plenum Press, 1984; 16-20.
8. Astell C, Blundell M. Sequence of the right hand terminal palindrome of the human parvovirus B19 genome has the potential to forma « stern plus arm » structure. Nucleic Acids Res 1989; 17: 5857-62.
9. Ozawa K, Ayub J, Yu-Shu H, Kurtzman G, Shimada T, Young N. Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol 1987; 61: 2395-406.
10. Brown K, Anderson S, Young N. Erythocyte P antigen: Cellular receptor for B19 parvovirus. Science 1993; 262: 114-7.
11. Brown K, Hibbs F, Gallinella G. Resistance to parvovirus B19 infection due to a lack of virus receptor (erythrocyt P antigen). N Engl J Med 1994; 330: 1192-6.
12. Cooling L, Koerner T, Naides S. Multiple glycoshingolipids determine the tissue tropism of parvovirus B19. J Infect Dis 1995; 172: 1198-205.
13. Takahashi T, Ozawa K, Takahashi K, Asano S, Takaku F. Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood 1990; 75: 603-10.
14. Sol N, Le Junter J, Vassias L, Preyasinier J, Thomas A, Prigent A. Possible interaction between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 1999; 73: 8762-70.
15. Cohen B, Buckley C. The prevalence of antibody to human parvovirus B19 in England and Wales. Microbiol 1988; 25: 151-3.
16. Disease PHLSwPoF. Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 1990; 300: 1166-70.
17. McOmish F, Yap P, Jordan A, Hart H, Cohen B, Simmonds P. Detection of parvovirus B19 in donated blood: A model system for screening by polymerase chain reaction. J Clin Microbiol 1993; 31: 323-8.
18. Anderson M, Higgins P, Davis L. Experimental parvoviral infection in humans. J Infect Dis 1985; 152: 257-65.
19. Portmore A. Parvoviruses (erythema infectiosum, aplastic crisis). Mandell GL, Benett, JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995; 1439-46.
20. Pattison J, Jones S, Hodgan J. Parvovirus infection ans hypoplastic anemia. Lancet 1981; 1: 1664-5.
21. Belloy M, Morinet M, Blondin G, Courouce A, Peyrol Y, Vilmer G. Erythroid hypoplasia due to chronic infection with parvovirus B19. N Engl J Med 1990; 322: 633-4.
22. Brown T, Anand A, Richie L, Clewley J, Reid T. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984; 2: 1033-4.
23. Harel L, Straussbreg R, Rudich H, Cohen A, Amir J. Raynaud's phenomenon as a manifestation of parvovirus B19 infection: Case reports and review of parvovirus B19 rheumatic and vasculitis syndromes. Clin Infect Dis 2000; 30: 500-3.
24. Leruez-ville M, Laugé A, Morinet F, Guillevin L, Dény P. Polyarteritis nodosa and parvovirus B19. Lancet 1994; 344: 263-4.
25. Yoto Y, Kudoh T, haseyama K, Suzuki N, Chiba S, Matsunaga Y. Human parvovirus B19 infection in Kawasaki disease. Lancet 1994; 344: 58-9.
26. Murry C, Jerome K, Reichenbach D. Fatal parvovirus myocarditis in a 5-year-old girl. Human Pathol 2001; 32: 342-5.
27. Marchand S, Tchernia G, Hiesse C, Tertian G, Cartron J, Kriaa F, Boubenider S, Goupy C, Lecointe D, Charpentier B. Human parvovirus B19 infection in organ transplant recipients. Clin Transplant 1999; 13: 17-24.
28. Griffin T, Squires J, Timmons C, Buchanan G. Chronic human parvovirus B19-induced erythroid hypoplasia as the initial manifestation of human immunodeficiency virus infection. J Pediatr 1991; 118: 899-901.
29. Gahr M, Pekrum A, Eiffert H. Persistence of parvovirus B19-DNA in blood of child with severe combined immunodeficiency associated with chronic pure red cell apalsia. Eur J Pediatr 1991; 150: 470-2.
30. Kurtzman G, Cohen B, Meyers P, Amunullah A, Young N. Persistant B19 parvovirus infection as a cause of severe chronic anemia in children with acute lymphocytic leukemia. Lancet 1988; 2: 1159-62.
31. Gallinella G, Manaresi E, Venturoli S, Grazi G, Musiani M, Zerbini M. Occurence and clinical role of active parvovirus B19 infection in transplant recipients. Eur J Clin Microbiol Infect Dis 1999; 18: 811-3.
32. Al-Khaldi N, Watson A, Harris A, Irving W. Dual infection with human herpse-virus type 6 and parvovirus B19 in a renal transplant recipient. Pediatr Nephrol 1994; 8: 349-50.
33. Sturm I, Watschinger B, Geissler K, Guber S, Popow-kraupp T, Horl W, Pohanka H. Chronic parvovirus B19 infection-associated pure red cell anemia in a kidney transplant recipient. Nephrol Dial Transplant 1996; 11: 1367-70.
34. Söderlund M, Von Essen R, haapasaari J, Kiitsala U, Kiviluoto O, Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthopathy Lancet 1997; 349: 1063-5.
35. Pillay D, Patou G, Griffiths P, Rees L. Secondary parvovirus B19 infection in an immunocompromised child. Pediatr Infect Dis J 1991; 10: 623-4.
36. Bertoni E, Rosati A, Znazzi M, Azzi A, Zakrzewfka K, Guidi S, Salvadori M. Severe apalstic anaemia due to B19 parvovirus infection in renal transplant recipient. Nephrol Dial Transplant 1995; 10: 1462-3.
37. Uemura N, Ozawa K, Tani K, Nishikawa M, Inoue S, Nagao T, Ushida H, Matsunago Y, Asano S. Pure red cell apalsia caused by parvovirus B19 infection in a renal transplant recipient. Eur J Haematol 1995; 54: 68-9.
38. Leray H, Canaud B, Cristol J, Jonquet O, Daprès G, Ortiz J, Mion C. Infection a parvovirus B19 révélée par une insuffisance rénale aiguë. Néphrologie 1992; 13: 123-5.
39. Murer L, Zacchelo G, Bianchi D, Dall'amico R, Montini G, Andreeta B, Perini M, Curro Dossi E, Zanon G, Zacchelo F. Thrombotic microangiopathy associated with parvovirus B19 infection after renal transplantation. J Am Soc Nephrol 2000; 11: 1132-7.
40. Mougdil A, Shidban H, Nast C, Bagga A, Aswad S, Graham S, Mendez R, Jordan S. Parvovirus B19 infection-related complications in renal transplant recipients. Transplantation 1997; 64: 1847-50.
41. Tanawattanacharoen S, Falk R, Jenette J, Kopp J. Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis 2000; 35: 1166-74.
42. Diaz F, Collazos J. Glomerulonephritis and Henoch-Shoenlein purpura associated with acute parvovirus B19 infection. Clin Nephrol 2000; 53: 237-8
43. Iwafuchi Y, Morita T, Kamimura A, Kunisada K, Ito K, Miyazaki S. Acute endocapillary proliferative glomerulonephritis associated human parvovirus 819 infection. Clin Nephrol 2002; 57: 246-50.
44. Taylor G, Drachenberg C, Faris-Young S. Renal involvement of human parvovirus B19 in an immunocompetent host. Clin Infect Dis 2001; 32: 167-9.
45. Mori N, Nose M, Miyazawa M, Kyogoku M, Wolfinbarger J, Bloom M. Interstitial nephritis in aleutian mink disease. Possible role of cell-mediated immunity against virus-infected tubular epithelial cells. Am J Pathol 1994; 144: 1326-33.
46. Lee P, Hung C, Lin Y, Wang J, Jan M, Lei H. A role for chronic parvovirus B19 infection in liver dysfunction in renal transplant recipients? Transplantation 2002; 73: 1635-9.
47. Pardi D, Romero Y, Mertz L, Douglas D. Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: A report of two cases and a review of the litterature. Am J Gastroenterol 1998; 93: 468-73.
48. Sokal E, Melchior M, Cornu C. Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet 1998; 352: 1739.
49. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S. Human parvovirus B19 infection associated with acute hepatitis. Lancet 1996; 347: 868.
50. Shan Y, Lee P, Wang J, Tsai H, Sung C, Jin Y: Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient. Nephrol Dial Transplant 2001; 16: 2420-2.
51. Showengerdt K, Ni J, Denfield S. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection. Circulation 1997; 96: 3549-54.
52. Nikkari S, Mertsola J, Korvenrata H, Vainionpaa R, Toivanen P. Wegener's granulomatosis and parvovirus B19 infection. Arthritis Rheum 1994; 37: 1707-10.
53. Jawad A. Lupus and parvovirus. Br J Rheumatol 1993; 32: 527-8.
54. Clewley J. Detection of human parvovirus using a moleculary clone probe. J Med Virol 1985; 15: 173-81.
55. Lundqvist A, Tolfvenstam T, Bostic J, Soderlund M, Brolinden K. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow. Scand J Infect Dis 1999; 31: 11-6.
56. Morinet F, Tchernia G. Le parvovirus B19 et l'hématopoï èse. Médecine/science 1991; 7: 127-37.
57. Shimmura H, tanabe K, Ishikawa N, Tokumoto T, Toda F, Toma H. Discontinuation of immunosuppressive antimetabolite for parvovirus B19-associated anemia in kidney transplant patients. Transplant Proc 2000; 32: 1967-9.
58. Levy J, Pusey C. Nephrotoxicity of intravenous immunoglobulin. QJM 2000; 93: 751-5.
59. Wong T, Chan P, Leung C, Szeto C, Tam J, Li P. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis 1999; 34: 1132-6.
60. Lui S, Luk W, Cheung C, Chan T, Lai K, Peiris J. Nosocomial outbreak of parvovirus B19 infection in a renal transplant unit. Transplantation 2001; 71: 59-64.
61. Corral D, Darras F, Jensen C, Hakala T, Naides S, Krause J, Starel T, Jordan M. Parvovirus B19 infection causing pure red cell aplasia in a recipient of pediatric donor kidney. Transplantation 1993; 55: 427-30.
62. Bertoni E, Rosati A, Zanazzi M, Azzi A, Zakrzewfka K, Guidi S, Salvadori M. Unusual incidence of aplastic anaemia due to B19 parvovirus infection in renal transplant recipients. Transplant Proc 1997; 29: 818-9.
63. Ashan N, Holman M, Gocke C, Groff J, Yang H. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation. Clin Transplant 1997; 11: 265-7.
64. So B, Chae K, Lee K, Lee Y, Jeong B. Pure red cell aplasia due to parvovirus B19 infection in a renal transplant patient: A case report. Transplant Proc 2000; 32: 1954-6.
65. Pamidi S, Friedman K, Kampalath B, Eshoa C, Hariharan S. Human parvovirus B19 infection presenting as persistent anemia in renal transplant recipient. Transplantation 2000; 69: 2666-9,
66. Liefeldt L, Buhl M, Schweickert B, Engelmann E, Sezer O, Lachinski P, Preuschof L, Neumayer H. Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy. Nephrol Dial Transplant 2002; 17: 1840-2.